Senti Biosciences, Inc. (SNTI)
NASDAQ: SNTI · Real-Time Price · USD
0.9303
+0.1081 (13.15%)
Feb 6, 2026, 4:00 PM EST - Market closed
Senti Biosciences Market Cap
Senti Biosciences has a market cap or net worth of $24.46 million as of February 9, 2026. Its market cap has increased by 13.81% in one year.
Market Cap
24.46M
Enterprise Value
41.80M
1-Year Change
13.81%
Ranking
Category
Stock Price
$0.93
Market Cap Chart
Since May 26, 2021, Senti Biosciences's market cap has decreased from $256.04M to $24.46M, a decrease of -90.45%. That is a compound annual growth rate of -39.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 24.46M | -10.55% |
| Dec 31, 2025 | 27.34M | 69.76% |
| Dec 31, 2024 | 16.11M | -45.22% |
| Dec 29, 2023 | 29.40M | -52.46% |
| Dec 30, 2022 | 61.84M | -78.72% |
| Dec 31, 2021 | 290.53M | 13.47% |
| May 26, 2021 | 256.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AEON Biopharma | 26.43M |
| Skye Bioscience | 26.26M |
| Boundless Bio | 25.97M |
| BriaCell Therapeutics | 25.95M |
| Lixte Biotechnology Holdings | 25.70M |
| Exicure | 25.69M |
| Serina Therapeutics | 25.56M |
| IO Biotech | 25.18M |